|
"蒲永孝"的相關文件
顯示項目 21-30 / 266 (共27頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma
|
Huang, Chao-Yuan; Huang, Ya-Li; Pu, Yeong-Shiau; Shiue, Horng-Sheng; Chen, Wei-Jen; Chen, Shih-Shan; Lin, Ying-Chin; Su, Chien-Tien; Hsueh, Yu-Mei; 蒲永孝; 黃昭淵 |
| 國立臺灣大學 |
2016 |
Recommended Initial Antimicrobial Therapy for Emphysematous Pyelonephritis: 51 Cases and 14-Year-Experience of a Tertiary Referral Center
|
Lu, Yu-Chuan; Hong, Jian-Hua; Chiang, Bing-Juin; Pong, Yuan-Hung; Hsueh, Po-Ren; Huang, Chao-Yuan; Pu, Yeong-Shiau; 呂育全; 蒲永孝; 薛博仁; 黃昭淵 |
| 國立臺灣大學 |
2016 |
Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma
|
Huang, Chao-Yuan; Pu, Yeong-Shiau; Shiue, Horng-Sheng; Chen, Wei-Jen; Lin, Ying-Chin; Hsueh, Yu-Mei; 蒲永孝; 黃昭淵 |
| 國立臺灣大學 |
2016 |
Perioperative changes in TGF-beta 1 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer
|
Wang, Alexander Sheng-Shin; Chen, Chung-Hsin; Chou, Yu-Ting; Pu, Yeong-Shiau; 蒲永孝; 陳忠信 |
| 國立臺灣大學 |
2016 |
Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma
|
Yang, Shu-Mei; Huang, Chao-Yuan; Shiue, Horng-Sheng; Pu, Yeong-Shiau; Hsieh, Yi-Hsun; Chen, Wei-Jen; Lin, Ying-Chin; Hsueh, Yu-Mei; 蒲永孝; 黃昭淵 |
| 國立臺灣大學 |
2016 |
Aristolochic Acid in the Etiology of Renal Cell Carcinoma
|
Hoang, Margaret L.; Chen, Chung-Hsin; Chen, Pau-Chung; Roberts, Nicholas J.; Dickman, Kathleen G.; Yun, Byeong Hwa; Turesky, Robert J.; Pu, Yeong-Shiau; Vogelstein, Bert; Papadopoulos, Nickolas; Grollman, Arthur P.; Kinzler, Kenneth W.; Rosenquist, Thomas A.; 蒲永孝; 陳保中; 陳忠信 |
| 國立臺灣大學 |
2016 |
Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study
|
Ye, D.; Ahn, H.; Pu, Y-S.; Weiqing, H.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Yamada, S.; Noda, S.; Sun, Y.; 蒲永孝 |
| 國立臺灣大學 |
2016 |
Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study
|
Ye, D.; Ahn, H.; Pu, Y-S.; Han, W.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Qi, J.; Zhou, F.; Sun, G.; Chen, L.; Xue, B.; Yamada, S.; Saito, M.; Suga, K.; Sun, Y.; 蒲永孝 |
| 國立臺灣大學 |
2015 |
Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
|
Hu, Che-Yuan; Tsai, Yu-Chieh; Wang, Shuo-Meng; Huang, Chao-Yuan; Tai, Huai-Ching; Chen, Chung-Hsin; Pu, Yeong-Shiau; Lin, Wei-Chou; Huang, Kuo-How; 戴槐青; 蒲永孝; 陳忠信; 蔡育傑; 黃昭淵; 林維洲; 黃國皓; 王碩盟 |
| 國立臺灣大學 |
2015 |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo, Kuan-Lin; Ho, I-Lin; Shi, Chung-Sheng; Wu, June-Tai; Lin, Wei-Chou; Tsai, Yu-Chieh; Chang, Hong-Chiang; Chou, Chien-Tso; Hsu, Chen-Hsun; Hsieh, Ju-Ton; Chang, Shih-Chen; Pu, Yeong-Shiau; Huang, Kuo-How; 蒲永孝; 張宏江; 吳君泰; 蔡育傑; 林維洲; 黃國皓; 謝汝敦 |
顯示項目 21-30 / 266 (共27頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
